Publications by authors named "John Copland"

Claim this Profile
O
Optimized CART Cell Therapy for Metastatic Aggressive Thyroid Cancer.
Claudia Manriquez Roman, Elizabeth L Siegler, Justyna J Gleba, Truc N Huynh, Grace E DeFranco, John A Copland

bioRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower Gene Expression Is Associated With Poor Survival Outcome and Treatment Response in Clear Cell Renal Cell Carcinoma: A Bioinformatics Analysis.
Marilyn D Saulsbury, Simone O Heyliger, Emanuela Taioli, Tamiel N Turley, Jordan P Reynolds, John A Copland

Cancer Genomics Proteomics· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET Imaging of Thyroid-Stimulating Hormone Receptor (TSHR) in Oncocytic Thyroid Carcinoma for Monitoring TSHR CAR T-Cell Therapy Response.
Wenhui Fu, Ephraim E Parent, Justyna J Gleba, Joshua A Knight, Saad J Kenderian, John A Copland

Bioconjug Chem· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Peroxisomal ABCD3 Transporter as a Prognostic Factor in Clear Cell Renal Cell Carcinoma.
Simone Heyliger, Tamiel N Turley, Tracoyia Roach, Marilyn D Saulsbury, Equar Taka, John A Copland

Cancer Genomics Proteomics· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical ImmunoPET Imaging of Thyroid-Stimulating Hormone Receptor Expression in Thyroid Cancer using [Cu]Cu-NOTA-TSHR-Ab.
Wenhui Fu, Ephraim E Parent, Justyna J Gleba, Joshua A Knight, Otto Muzik, John A Copland

Mol Pharm· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET imaging of differentiated thyroid cancer with thyrotropin-alfa.
Grayson R Gimblet, Pratheek Reddy, Michelle M Holland, Hailey A Houson, Jason Whitt, John A Copland

Sci Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human iPSC-Derived MSCs Induce Neurotrophic Effects and Improve Metabolic Activity in Acute Neuronal Injury Models.
Keiji Kawatani, Genesis Omana Suarez, Ralph B Perkerson, Ephraim E Parent, Toshihiko Nambara, John A Copland

J Neurosci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Acute leukemias: molecular characterization, leukemia-initiating cells, and influence of the microenvironment, volume II.
Lokman Varisli, Garrett M Dancik, John A Copland, Spiros A Vlahopoulos

Front Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppression.
Ana-Maria Sigarteu Chindris, Michael Rivera, Yaohua Ma, Asha Nair, Yi Liu, John A Copland

Front Endocrinol (Lausanne)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zirconium- 89 Labeled Antibody K1-70 for PET Imaging of Thyroid-stimulating Hormone Receptor Expression in Thyroid Cancer.
Ephraim E Parent, Justyna J Gleba, Joshua A Knight, Saad J Kenderian, John A Copland

Mol Imaging Biol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension.
Jason Shirian, Alexandra Hockla, Justyna J Gleba, Matt Coban, Naama Rotenberg, John A Copland

Biomolecules· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET Imaging of Differentiated Thyroid Cancer with TSHR-Targeted [Zr]Zr-TR1402.
Grayson R Gimblet, Hailey A Houson, Jason Whitt, Pratheek Reddy, John Al Copland

Mol Pharm· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer.
Adam M Kase, Justyna Gleba, James L Miller, Erin Miller, Joachim Petit, John A Copland

Mol Cancer Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension.
Jason Shirian, Alexandra Hockla, Justyna J Gleba, Matt Coban, Naama Rotenberg, John A Copland

bioRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma.
Peter Y F Zeng, Stephenie D Prokopec, Stephen Y Lai, Nicole Pinto, Michelle A Chan-Seng-Yue, John A Copland

Cell Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.
Jaime M Pita, Eric Raspé, Katia Coulonval, Myriam Decaussin-Petrucci, Maxime Tarabichi, John A Copland

Front Endocrinol (Lausanne)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer.
Grayson R Gimblet, Jason Whitt, Hailey A Houson, Diana Lin, Rachael Guenter, John A Copland

Surgery· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR screening identifies BET and mTOR inhibitor synergy in cholangiocarcinoma through serine glycine one carbon.
Yan Zhu, Dengyong Zhang, Pooja Shukla, Young-Ho Jung, Prit Benny Malgulwar, John A Copland

JCI Insight· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiosynthesis and Preliminary Evaluation of [C]SSI-4 for the Positron Emission Tomography Imaging of Stearoyl CoA Desaturase 1.
Kang-Po Li, Justyna J Gleba, Ephraim E Parent, Joshua A Knight, John A Copland

Mol Pharm· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Bivalent Bromodomain Inhibitor MT-1 Inhibits Prostate Cancer Growth.
Sanjeev Shukla, Carlos Riveros, Mohammed Al-Toubat, Jonathan Chardon-Robles, Teruko Osumi, John A Copland

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer.
Tin-Lok Wong, Jia-Jian Loh, Shixun Lu, Helen H N Yan, Hoi Cheong Siu, John A Copland

Nat Commun· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete response in Patients With Lung-Only Metastatic Prostate Cancer: Outcome Analysis.
Adam M Kase, John A Copland, Qihui Zhai, Winston Tan

Clin Genitourin Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy.
Jing Deng, Aneel Paulus, Douglas D Fang, Alak Manna, Guangfeng Wang, John A Copland

Clin Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting BCAT1 Combined with α-Ketoglutarate Triggers Metabolic Synthetic Lethality in Glioblastoma.
Bo Zhang, Hui Peng, Mi Zhou, Lei Bao, Chenliang Wang, John A Copland

Cancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YM155 Induces DNA Damage and Cell Death in Anaplastic Thyroid Cancer Cells by Inhibiting DNA Topoisomerase IIα at the ATP-Binding Site.
Ryan P Mackay, Paul M Weinberger, John A Copland, Elahe Mahdavian, Qinqin Xu

Mol Cancer Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis